enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   The FDA approval for Zenrelia carries a boxed warning stating that dogs should not be vaccinated at least 28 days before and after treatment with the drug, due to the risk of fatal vaccine-induced ...

3. Bedinvetmab - Wikipedia

   en.wikipedia.org/wiki/Bedinvetmab

   Half the dogs received bedinvetmab and half the dogs received a sterile saline injection every 28 days for a total of three doses. [5] Before treatment and on various days throughout the study, owners used the Canine Brief Pain Inventory (CBPI) assessment tool to measure the severity of the dog's pain and the degree to which the pain interfered ...

4. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

   www.aol.com/skin-conditions-dogs-symptoms-causes...

   A vet explains the most common skin conditions in dogs and the treatments available. ... Dr. MacMillan recommends using a vet-approved anti-parasite product, treating your home with a flea spray ...

5. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious infections.

6. Lokivetmab - Wikipedia

   en.wikipedia.org/wiki/Lokivetmab

   Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]

7. US FDA approves Elanco's treatment for parasitic infections ...

   www.aol.com/news/us-fda-approves-elancos...

   The drug, branded as Credelio Quattro, is a single, monthly chewable tablet for dogs eight weeks of age or older, the company said. The drug is approved for the treatment of flea and tick ...